JANUARY, 2006
Valued Shareholders:
In summary, in the coming year, we will intensify our product development efforts with our own synDNA™, increase our efforts to secure government contracts for bio-defense applications, proceed with development of synDNA™ production and maintain scientific research necessary to move the company forward. It promises to be an exciting time.
Very truly yours,
Malcolm Skolnick
The last time CYGX closed at 0.86 was 1/31/06.
"If the facts don't fit the theory, change the facts."